An ambulatory infusion pump is a tiny battery-operated pump that gradually infuses your body with medications like chemotherapy or antibiotics. The pump releases medication over a predetermined period of time determined by your doctor. You may continue the majority of your daily tasks at home with the help of an AIP and avoid having to spend the night at the hospital.
 |
| To learn more about this report: https://bit.ly/3IzqJzC |
Ambulatory services, which are a form of outpatient treatment, are rapidly growing in demand in North America as a result of the expanding population and demand on the healthcare system. This is mostly due to the fact that these treatments are more practical and affordable than those provided by conventional hospitals.
As a result, there are now many more ambulatory surgery centers (ASCs) than ever before in the U.S. The shorter stays, lesser risk of infections, quicker healing, and novel technology that ASCs provide can also be credited for their popularity.
Due to a shortage of visiting time and a heavy caseload, ambulatory services are becoming preferred over inpatient treatment in this aspect. Thus, the usage of infusion pumps in the area is influenced by the rising need for ambulatory services for the treatment of chemotherapy, diabetes, and other medical treatments.
The North American ambulatory infusion pumps market is predicted to reach $1,989.8 million by 2030 due to the increasing incidence of chronic illnesses, rising elderly and diabetic populations, and surging need for ambulatory services.
In the application category of ambulatory infusion pumps in North America, diabetes had the highest revenue share of around 30%. This is because diabetes and its effects are becoming more common in the area. A whopping 96 million adults in the U.S., or 38.0% of the adult population, have prediabetes.
An infusion pump substitutes the requirement for many daily injections with a continuous insulin infusion by dispensing dosages of insulin at predetermined times. As a result, the need for ambulatory infusion pumps is anticipated to increase as the number of diabetes patients rises over time.
Additionally, the advancements in wearable diabetes control devices and their protracted infusion times are to blame for their growing popularity.
Due to the existence of significant competitors, a well-developed healthcare infrastructure, benevolent reimbursement rules, and the rising frequency of chronic illnesses, the U.S. controlled a bigger share.
Additionally, the proliferation of alternative healthcare settings and the adoption of various home infusion services are factors in the sector. It is predicted that the U.S.'s substantial hospital population will continue to fuel regional demand.
A total of 6,093 hospitals, including 1,228 investor-owned (for-profit) community hospitals and 2,960 non-government not-for-profit community hospitals, were in operation in the United States as of 2010, according to the American Hospital Association (AHA).
In terms of product categories, the demand for ambulatory infusion pumps was dominated by accessories and consumables. This is mainly because they make repeat purchases and a variety of accessories and consumables are readily available around the region.
Over 40% of the demand was accounted for by devices. This is mostly attributable to these pumps' great availability and increased demand due to their convenience in providing medications for a variety of diseases.
